JCELL Trademark

Trademark Overview


On Monday, June 21, 2021, a trademark application was filed for JCELL with the United States Patent and Trademark Office. The USPTO has given the JCELL trademark a serial number of 90978802. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by jCyte, Inc.. The JCELL trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Stem cell therapy services; Medical services relating to the removal, treatment and processing of stem cells in the nature of stem cell technology for generating innovative cell therapy; Information, advice and consultancy services relating to medical services and regenerative medicine

Scientific research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of technology in the field of biological cell manufacturing; Providing information about medical research and scientific research; Development of therapeutics and cell therapies; custom engineering of biological cells; Technology platforms for developing and engineering cells and cell therapies
jcell

General Information


Serial Number90978802
Word MarkJCELL
Filing DateMonday, June 21, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7009322
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesStem cell therapy services; Medical services relating to the removal, treatment and processing of stem cells in the nature of stem cell technology for generating innovative cell therapy; Information, advice and consultancy services relating to medical services and regenerative medicine
Goods and ServicesScientific research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of technology in the field of biological cell manufacturing; Providing information about medical research and scientific research; Development of therapeutics and cell therapies; custom engineering of biological cells; Technology platforms for developing and engineering cells and cell therapies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 6, 2021
Primary Code042
First Use Anywhere DateThursday, May 7, 2020
First Use In Commerce DateThursday, May 7, 2020

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 6, 2021
Primary Code044
First Use Anywhere DateThursday, May 7, 2020
First Use In Commerce DateThursday, May 7, 2020

Trademark Owner History


Party NamejCyte, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Party NamejCyte, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Party NamejCyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 7, 2022DIVISIONAL PROCESSING COMPLETE
Friday, September 9, 2022DIVISIONAL REQUEST RECEIVED
Thursday, December 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 18, 2022ASSIGNED TO LIE
Thursday, September 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 9, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, March 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 11, 2022NON-FINAL ACTION E-MAILED
Friday, March 11, 2022NON-FINAL ACTION WRITTEN
Friday, March 11, 2022ASSIGNED TO EXAMINER
Monday, September 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 24, 2021NEW APPLICATION ENTERED